Clinical Trial Update: An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the MVA-BN vaccine to prevent Mpox infection in adults living with HIV in Kinshasa, DRC; the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• MVA-BN (Modified vaccinia Ankara Bavarian Nordic)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Mpox (Monkeypox) | Phase 2 | Status: RECRUITING